Skip to content

News

Warner to succeed Hart as CEO of Kinney parent

Warner to succeed Hart as CEO of Kinney parent

Bridget-ann Hart will retire as president and chief executive officer of Kinney Drugs operator KPH Healthcare Services Inc. at the end of the year. She will continue to serve on the board of KPH, a national provider of health care services with more than 4,000 employees across four divisions.

United call at TSE for DIR fee relief

United call at TSE for DIR fee relief

Leaders of the National Association of Chain Drug Stores thanked attendees at the organization’s Total Store Expo for their dedication around such issues as direct and indirect remuneration (DIR) fee reform and opiate misuse. “We have big issues. We have big ideas.

Boiron celebrates grand opening of new headquarters

Boiron celebrates grand opening of new headquarters

Homeopathic medicine manufacturer Boiron Inc. celebrated the grand opening of its new headquarters here at 4 Campus Boulevard Tuesday, September 17. The new building is adjacent to the company’s old headquarters, but at some 32,000 square feet, is double the size.

Changing retail landscape focus of Emerson Industry Day

Changing retail landscape focus of Emerson Industry Day

With digital marketing and e-commerce creating a tsunami of change across the retail industry, accentuated by Amazon’s seemingly unstoppable growth and the emergence of Alibaba, China’s giant e-commerce company, it was fitting that “Adaptability” was the theme of Emerson Group’s annual Industry Day

Diplomat considers sale, merger

Diplomat considers sale, merger

Diplomat Pharmacy is considering a sale or merger after seeing revenue declines in its PBM and specialty segments in the second quarter ended June 30. The company’s board ordered the exploration of “strategic alternatives” after Diplomat’s quarterly revenue dropped 9% from the year-ago period to $1.

CVS addresses sunscreen concerns

CVS addresses sunscreen concerns

CVS Health announced it will be taking another step forward in its efforts to remove chemicals of concern to consumers by eliminating oxybenzone and octinoxate from nearly 60 CVS Health brand sunscreen products under SPF 50 by the end of 2020.

CVS plans 1,500 HealthHUBs

CVS plans 1,500 HealthHUBs

The executive team of CVS Health outlined a series of transformation initiatives at its 2019 Investor Day event last month, showing how the company plans to accelerate enterprise growth, simplify a consumer health system that is confusing and inconvenient, and position the company for long-term grow